Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats

References

• Agrawal R, Sandhu SK, Sharma I, Kaur IP. (2014). Development and evaluation of curcumin-loaded elastic vesicles as an effective topical anti-inflammatory formulation. AAPS PharmSciTech 16:1–11
   Google Scholar
• Barthomeuf, C, Chollet, P, Bayet-Robert, M. (2010). Curcuminoids in combination docetaxel for the treatment of cancer and tumour metastasis. Google Patents No. US 20120022148 A1, 1-7
   Google Scholar
• Beija M, Salvayre R, Lauth-de Viguerie N, Marty JD. (2012). Colloidal systems for drug delivery: from design to therapy. Trends Biotechnol 30:485–96
   PubMed Web of Science ®Google Scholar
• Chauhan MS, Kumar A, Pathak K. (2012). Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design. AAPS PharmSciTech 13:1492–501
   PubMed Web of Science ®Google Scholar
• Cho H, Lai TC, Tomoda K, Kwon GS. (2014). Polymeric micelles for multi-drug delivery in cancer. AAPS PharmSciTech 16:111
   Google Scholar
• Choubey AK, Dora CP, Bhatt TD, et al. (2014). Development and evaluation of PEGylated Enoxaparin: a novel approach for enhanced anti-Xa activity. Bioorg Chem 54:1–6
   PubMed Web of Science ®Google Scholar
• Ferlay J, Autier P, Boniol M, et al. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–92
   PubMed Web of Science ®Google Scholar
• Finn RS, Dering J, Ginther C, et al. (2007). Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro. Breast Cancer Res Treat 105:319–26
   PubMed Web of Science ®Google Scholar
• Hu Q, Rijcken CJ, Bansal R, et al. (2015). Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles. Biomaterials 53:370–8
   PubMed Web of Science ®Google Scholar
• Italia J, Yahya M, Singh D, Kumar MR. (2009). Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone®. Pharm Res 26:1324–31
   PubMed Web of Science ®Google Scholar
• Jain AK, Swarnakar NK, Godugu C, et al. (2011). The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials 32:503–15
   PubMed Web of Science ®Google Scholar
• Jinturkar KA, Anish C, Kumar MK, et al. (2012). Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines. Biomaterials 33:2492–507
   PubMed Web of Science ®Google Scholar
• Kawalec P, Łopuch S, Mikrut A. (2014). Effectiveness of targeted therapy in patients with previously untreated metastatic breast cancer: a systematic review and meta-analysis. Clin Breast Cancer 15:90–100
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Anand P, Aggarwal BB. (2008). Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199–225
   PubMed Web of Science ®Google Scholar
• Kutty RV, Fen SS. (2013). Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers. Biomaterials 34:10160–71
   PubMed Web of Science ®Google Scholar
• Leamon CP, Low PS. (1991). Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA 88:5572–6
   PubMed Web of Science ®Google Scholar
• Li W Jr, Szoka FC. (2007). Lipid-based nanoparticles for nucleic acid delivery. Pharm Res 24:438–49
   PubMed Web of Science ®Google Scholar
• Li X, Wang D, Zhang J, Pan W. (2009). Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers. J Pharm Pharmacol 61:1485–92
   PubMed Web of Science ®Google Scholar
• Liu Y, Li K, Pan J, et al. (2010). Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Biomaterials 31:330–8
   PubMed Web of Science ®Google Scholar
• Lopes NM, Adams EG, Pitts TW, Bhuyan BK. (1993). Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharm 32:235–42
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. (2001). Long circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318
   PubMed Web of Science ®Google Scholar
• Mulik RS, Mönkkönen J, Juvonen RO, et al. (2010). Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm 398:190–203
   PubMed Web of Science ®Google Scholar
• Olivier JC, Huertas R, Lee HJ, et al. (2002). Synthesis of pegylated immunonanoparticles. Pharm Res 19:1137–43
   PubMed Web of Science ®Google Scholar
• Payam Z, Raquel D, Loan H, et al. (2011). Combination drug delivery strategy for the treatment of multidrug resistant ovarian cancer. Mol Pharm 8:260–9
   PubMed Web of Science ®Google Scholar
• Reuter S, Eifes S, Dicato M, et al. (2008). Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76:1340–51
   PubMed Web of Science ®Google Scholar
• Sarkar FH, Li Y. (2006). Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66:3347–50
   PubMed Web of Science ®Google Scholar
• Shegokar R, Singh K, Müller R. (2011). Production & stability of stavudine solid lipid nanoparticles – from lab to industrial scale. Int J Pharm 416:461–70
   PubMed Web of Science ®Google Scholar
• Tan SW, Billa N. (2014). Lipid effects on expulsion rate of amphotericin B from solid lipid nanoparticles. AAPS PharmSciTech 15:287–95
   PubMed Web of Science ®Google Scholar
• Ullah MF. (2008). Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy. Asian Pac J Cancer Prev 9:1–6
   PubMed Web of Science ®Google Scholar
• Ungaro F, Conte C, Ostacolo L, et al. (2012). Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. Nanomedicine 8:637–46
   PubMed Web of Science ®Google Scholar
• Venkateswarlu V, Manjunath K. (2004). Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release 95:627–38
   PubMed Web of Science ®Google Scholar
• Vivek K, Reddy H, Murthy RS. (2007). Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 8:16–24
   PubMed Web of Science ®Google Scholar
• Wong MY, Chiu GN. (2011). Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model. Nanomedicine 7:834–40
   PubMed Web of Science ®Google Scholar
• Yamada K, Hikosaka M, Toda A, et al. (2003). Equilibrium melting temperature of isotactic polypropylene with high tacticity: 1. Determination by differential scanning calorimetry. Macromolecules 36:4790–801
   Web of Science ®Google Scholar
• Yuan H, Miao J, Du YZ, et al. (2008). Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm 348:137–45
   PubMed Web of Science ®Google Scholar
• Yueying H, Yan Z, Chunhua G, et al. (2010). Micellar carrier based on methoxy poly(ethylene glycol)-block-poly(ɛ-caprolactone) block copolymers bearing ketone groups on the polyester block for doxorubicin delivery. J Mater Sci Mater Med 21:567–74
   PubMed Web of Science ®Google Scholar